We are pleased to announce that the Irish Kidney Association is accepting applications as part of the HRCI-HRB Joint Funding Scheme 2022.
The Irish Kidney Association is a member of Health Research Charities Ireland (HRCI- formerly Medical Research Charities Group), which was founded in 1998 with the aim of supporting charities in Ireland to increase both the quality and quantity of healthcare research being done in Ireland. The HRCI represents the joint interests of charities specialising in restoring health through medical research, diagnosis and treatment and, where possible, the prevention of disease.
The HRCI-HRB Joint Funding Scheme aims to fund researchers and research teams to conduct internationally competitive and innovative research in areas of strategic relevance to each charity. HRCI-HRB awards are up to a maximum total award value of €300,000 for projects from 12 – 36 months.
The Irish Kidney Association will run our own call, in collaboration with the Irish Nephrology society, based on our strategic priorities, but will be using the standard application guidance and forms provided by the HRB.
The IKA awards are up to a maximum total award value of €200,000 for projects from 12 – 36 months. (The IKA will contribute €100,000 and the HRB will contribute €100,000)
How to apply
Applicants (Primary Investigator) must email their expression of interest application in a document to email@example.com by Friday 15th October 2021. This document must provide an outline of the application, including:
- Proposed Project Title
This should be at most 2 pages in length (max 11 font, normal margins). Project aims and Methodology must be clearly outlined. This will be assessed for eligibility and adherence to the strategic goals of IKA. In particular, applicants to the Joint Funding Scheme must address their approach to the following strategic principles:
- The proposed research must be of high scientific calibre within the domain of chronic kidney disease.
- The pathway to impact to improve the lives of patients with chronic kidney disease must be clearly articulated.
- The proposed research should contribute to the Irish and international renal research ecosystem and demonstrate collaboration that strengthens this.
- 5 Keywords
- Full Application Team
Patient and public involvement (PPI) is a key part of this research. For the purpose of this call, this is defined as: “PPI is research carried out “with” or “by” patients/members of the public rather than “to”,” about” or “for” them.
Priority will be given to submissions with a strong PPI orientation. For more details, please see A toolkit for research charities for a PPI relationship.pdf – Google Drive
Submissions should fall into one of the following categories:
- Applied clinical research: (which involves human participants, with a focus on developing diagnostic methods, clinical or surgical interventions, prevention research, diagnostic research, screening research, quality of life research or epidemiology research in the field of kidney disease). EXCLUDED Studies aimed at evaluating a full scale, definitive intervention to provide evidence on the efficacy, effectiveness, cost and broad impact of the intervention, and stand-alone feasibility studies conducted in preparation for a future definitive intervention. Such studies are supported through the HRB Definitive Intervention and Feasibility Awards (DIFA) scheme.
- Population health research (that investigates factors influencing health and illness in whole populations, as well as the evaluation of health policies and interventions that target population health outcomes)
- Health services research (which focuses on the different types of services provided by health systems, covering access to health services, costs and benefits of health services, national health policies and evaluating the impact of health service delivery on patient and service user outcomes)
- Psychological and social research on health (which examines the psychological and social processes that impact on and arise from the experience of chronic kidney disease and its treatment, and interventions to improve self-management of chronic kidney disease).
The outline strategy governing IKA priorities is shown in Appendix One.
Applicants should note updates to this call will be issued via the HRCI website and should prepare their application in conjunction with the guidelines on the HRCI website as well as the IKA guidance document. See https://hrci.ie/joint-funding-how/